17 studies found for:    Open Studies | "Hemorrhagic Fever, Ebola"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Ebola Virus Disease Survivors: Clinical and Immunologic Follow-up
Condition: Ebola Virus Disease
Intervention:
2 Recruiting A Prospective, Open Label, Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
Condition: Acute Ebola Virus Infection
Intervention: Biological: INTERCEPT Plasma
3 Recruiting Clinical Trial of the cAd3-EBO and cAd3-EBOZ Ebola Vaccines in Healthy Adults in Uganda
Condition: Hemorrhagic Fever, Ebola
Interventions: Biological: cAd3-EBOZ;   Biological: cAd3-EBO
4 Recruiting Efficacy of Favipiravir Against Ebola (JIKI)
Condition: Ebola Virus Disease
Intervention: Drug: Favipiravir
5 Not yet recruiting Multiple Treatments for Ebola Virus Disease (EVD)
Condition: Ebola Virus Disease
Interventions: Drug: Azithromycin;   Drug: Sunitinib and Erlotinib;   Drug: Atorvastatin and Irbesartan;   Other: IV fluids and laboratory testing
6 Recruiting STRIVE (Sierra Leone Trial to Introduce a Vaccine Against Ebola)
Condition: Hemorrhagic Fever, Ebola
Intervention: Biological: rVSVΔG-ZEBOV
7 Recruiting Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea
Condition: Hemorrhagic Fever, Ebola
Intervention: Other: Convalescent Plasma
8 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of Convalescent Plasma for Ebola Treatment
Condition: Ebola Virus Disease
Intervention: Procedure: Convalescent Plasma Treatment
9 Recruiting Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
Condition: Ebola Virus Infection
Interventions: Drug: TKM-100802 for Injection;   Drug: Placebo
10 Recruiting A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.
Condition: Ebola Virus Disease
Intervention: Biological: Ad5-EBOV
11 Recruiting Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)
Conditions: Ebola Virus Disease;   Hemorrhagic Fever
Intervention: Biological: VRC-EBOADC069-00-vp
12 Not yet recruiting Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)
Condition: Ebola Virus Disease
Interventions: Drug: Best Supportive Care;   Drug: Best Supportive Care + Amiodarone
13 Recruiting A Phase I Study to Assess Ebola Vaccines cAd3-EBO Z and MVA-EBO Z
Condition: Ebola Virus Disease
Interventions: Biological: MVA-EBO Z;   Biological: ChAd3-EBO Z
14 Recruiting A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430
Conditions: Filovirus Infections;   Ebola Virus Infection
Interventions: Drug: BCX4430;   Drug: Placebo
15 Recruiting VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Interventions: Biological: VRC-EBOMVA079-00-VP (MVA-EbolaZ);   Biological: VRC-EBOADC069-00-VP (cAd3-EBO)
16 Recruiting Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Interventions: Biological: VRC-EBOADC069-00-VP;   Biological: VRC-EBOADC076-00-VP
17 Recruiting Partnership for Research on Ebola Vaccines in Liberia (PREVAIL)
Condition: Ebola Virus
Interventions: Biological: VSVG-ZEBOV;   Biological: ChAd3-EBO Z;   Drug: Placebo

Indicates status has not been verified in more than two years